NYSE: DPLO

-0.15 -2.85% $ 5.11 Volume: 839,855 Common Stock | 20 minute delay May 23, 2019

Improving Our Value by Improving Our Care

Diplomat (NYSE: DPLO) is the nation’s largest independent provider of specialty pharmacy and infusion services. Diplomat helps people with complex and chronic health conditions in all 50 states, partnering with payers, providers, hospitals, manufacturers, and more. Rooted in deep specialty-pharmacy expertise, Diplomat’s innovative service model unites complementary brands to anticipate market needs, create shareholder value, and drive better patient outcomes.

Date Filing Filing Description Download
May 13, 2019 4 Statement of Changes in Beneficial Ownership
May 13, 2019 3 Initial Statement of Beneficial Ownership
May 10, 2019 10-Q Quarterly Report

NYSE: DPLO

-0.15 -2.85% $ 5.11 Volume: 839,855 Common Stock | 20 minute delay May 23, 2019

Investor Contact

Terri Anne Powers,
Vice President, Investor Relations
Diplomat Pharmacy Inc.
tpowers@diplomat.is
Phone: 312.889.5244

Email Now